Drug approvals top 2014 high but R&D returns still struggle

LONDON (Reuters) - The number of new drugs approved in the United States this year has already topped last year's 18-year high, yet large pharmaceutical companies are still struggling to get a decent return on their research dollars.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro